Table 3. Major adverse cardiovascular events in different mean platelet volume groups.
| High MPV (> 9.0 fl) (n = 305) | Medium MPV (7.9-9.0 fl) (n = 517) | Low MPV (< 7.9 fl) (n = 272) | p value* | |
| Total MACE | 112 (36.7) | 164 (31.7) | 76 (27.9) | 0.024 |
| All-cause mortality | 54 (17.7) | 56 (10.8) | 33 (12.1) | 0.039 |
| Target vessel revascularization | 33 (10.8) | 61 (11.8) | 22 (8.1) | 0.31 |
| Recurrent ACS | 58 (19.0) | 107 (20.7) | 43 (15.8) | 0.354 |
| Stroke | 5 (1.6) | 1 (0.2) | 4 (1.5) | 0.76 |
Data are presented as N (%).
* p value for trend was analyzed by linear-by-linear association.
ACS, acute coronary syndrome; MACE, major adverse cardiovascular events; MPV, mean platelet volume.